Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response (Q37818749)

23 August 2017

title

Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response (English)

1 reference

23 August 2017

0 references

11

0 references

author name string

Robert E Elliott

1

1 reference

23 August 2017

Amr Morsi

2

1 reference

23 August 2017

Stephen P Kalhorn

3

1 reference

23 August 2017

Joshua Marcus

4

1 reference

23 August 2017

Jonathan Sellin

5

1 reference

23 August 2017

Matthew Kang

6

1 reference

23 August 2017

Alyson Silverberg

7

1 reference

23 August 2017

Edwin Rivera

8

1 reference

23 August 2017

Eric Geller

9

1 reference

23 August 2017

Chad Carlson

10

1 reference

23 August 2017

Werner K Doyle

12

1 reference

23 August 2017

publication date

8 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

20

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

57-63

1 reference

Early identification of refractory epilepsy

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Subpectoral implantation of the vagus nerve stimulator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Outcome measurement after vagal nerve stimulation therapy: proposal of a new classification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation therapy after failed cranial surgery for intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Long-term multicenter experience with vagus nerve stimulation for intractable partial seizures: results of the XE5 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagal nerve stimulation in refractory epilepsy: the first 100 patients receiving vagal nerve stimulation at a pediatric epilepsy center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation: clinical experience in a large patient series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation for refractory epilepsy: a transatlantic experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Antiepileptic drug use during the first 12 months of vagus nerve stimulation therapy: a registry study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Long-term vagus nerve stimulation in the treatment of Lennox-Gastaut syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation: clinical experience in drug-resistant pediatric epileptic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Efficacy of vagal nerve stimulation in children with medically refractory epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Long-term effects of 24-month treatment with vagus nerve stimulation on behaviour in children with Lennox-Gastaut syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Vagus nerve stimulation for medically refractory epilepsy; efficacy and cost-benefit analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Complications of vagal nerve stimulation for epilepsy in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

Outcomes of epilepsy surgery in adults and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.10.017

10.1016/J.YEBEH.2010.10.017

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference